[Company Performance]: NORVA.ST's stock price is directly influenced by its financial health, including revenue, profit margins, debt levels, and earnings reports. Positive performance typically leads to increased investor confidence and higher stock value.

[Industry Trends]: The overall health and growth prospects of the pharmaceutical and biotechnology sectors impact NORVA.ST. Positive industry trends usually have a positive effect.

[Market Sentiment]: General investor confidence and market volatility influence all stocks, including NORVA.ST. Bull markets often lift stock prices, while bear markets have the opposite effect.

[Economic Conditions]: Macroeconomic factors such as interest rates, inflation, and GDP growth can affect investor sentiment and company profitability, impacting NORVA.ST's stock price.

[Regulatory Environment]: Changes in regulations related to drug development, approvals, and pricing can significantly impact NORVA.ST's future prospects and stock value.

[Competition]: The competitive landscape in the pharmaceutical market affects NORVA.ST. Strong competitors can affect the profitability and the market capitalization of the company.

[News and Events]: Company-specific news, such as drug trial results, partnerships, or acquisitions, can cause rapid fluctuations in NORVA.ST's stock price.

[Investor Sentiment]: How investors perceive the company and its future prospects influences trading activity and stock price. Positive sentiment drives up the price while negative sentiment has the opposite effect.